Drug Approval | August 19, 2022
Tavneos recommended by England’s NICE for the treatment of AAV
The decision follows authorization from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) in May 2022.
The decision follows authorization from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) in May 2022.
CEPI will provide seed funding of up to US$2.5 million to Codiak BioSciences.
AstraZeneca also played a critical role in the global response to COVID-19.
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
Pioneering Medicines and Novo Nordisk Bio Innovation Hub will leverage Flagship Pioneering’s bioplatform companies to create a portfolio of research programmes within cardiometabolic and rare diseases
Pharmapack trends are a key barometer of global device and packing opportunities in 2022
This collaboration strengthens Akron’s portfolio of off-the-shelf gene-editing technologies while broadening Vor Bio’s collection of nucleases to engineer gene-modified cell therapies
Companies plan to commercialize breath-based detection of lung infection and transplant rejection
First launches expected in H1 2022
Subscribe To Our Newsletter & Stay Updated
